CIBMTR Reporting Implementation Guide
0.1.8 - Trial Use 1

This page is part of the CIBMTR Reporting Implementation Guide (v0.1.8: Release Draft) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example MedicationAdministration: MedicationAdministration-Example2

Generated Narrative: MedicationAdministration MedicationAdministration-Example2

status: Completed

medication: ETOPOSIDE 20 MG/ML IV SOLN

subject: Female, DoB Unknown ( http://terminology.cibmtr.org/identifier/CRID#123456)

effective: 2020-07-22 16:58:05+0000

reasonCode: Cancer (CMS/HCC)

request: MedicationRequest: status = active; intent = order; medication[x] = ->etoposide (VEPESID) chemo IVPB; authoredOn = 2020-07-21 14:17:00+0000; reasonCode = Malignant neoplastic disease (disorder)

Dosages

-RouteMethodDose
*Intravenous routeInject - dosing instruction imperative (qualifier value)73 milligram (Details: UCUM codemg = 'mg')